title: Use of sensors in the treatment and follow-up of patients with diabetes mellitus.
abstract: Glucose control is the cornerstone of Diabetes Mellitus (DM) treatment. Although self-regulation using capillary glycemia (SRCG) still remains the best procedure in clinical practice, continuous glucose monitoring systems (CGM) offer the possibility of continuous and dynamic assessment of interstitial glucose concentration. CGM systems have the potential to improve glycemic control while decreasing the incidence of hypoglycemia but the efficiency, compared with SRCG, is still debated. CGM systems have the greatest potential value in patients with hypoglycemic unawareness and in controlling daily fluctuations in blood glucose. The implementation of continuous monitoring in the standard clinical setting has not yet been established but a new generation of open and close loop subcutaneous insulin infusion devices are emerging making insulin treatment and glycemic control more reliable.
authors.affiliation: Endocrinology and Nutrition Service, Hospital Puerta del Mar, Ana de Viya 21, 11009 Cadiz, Spain. isabeltoba@gmail.com
authors.forename: Isabel
authors.initials: I
authors.lastname: Torres
authors.forename: Maria G
authors.initials: MG
authors.lastname: Baena
authors.forename: Manuel
authors.initials: M
authors.lastname: Cayon
authors.forename: Jose
authors.initials: J
authors.lastname: Ortego-Rojo
authors.forename: Manuel
authors.initials: M
authors.lastname: Aguilar-Diosdado
mesh_terms: D015374:Biosensing Techniques / Q000295:instrumentation* / Q000379:methods*; D001786:Blood Glucose / Q000032:analysis; D015190:Blood Glucose Self-Monitoring / Q000295:instrumentation / Q000379:methods; D003920:Diabetes Mellitus / Q000628:therapy*; D005500:Follow-Up Studies; D006801:Humans; D007003:Hypoglycemia / Q000628:therapy; D055104:Infusions, Subcutaneous; D007328:Insulin / Q000008:administration & dosage
chemical_list: D001786:Blood Glucose; D007328:Insulin